Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 372

    1.

    Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

    Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, Sachs DP, Wolter TD, Buist AS, Johnston JA, White JD.

    Ann Intern Med. 2001 Sep 18;135(6):423-33.PMID: 11560455 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

    Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR; Varenicline Phase 3 Study Group.

    JAMA. 2006 Jul 5;296(1):47-55.PMID: 16820546 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia.

    Evins AE, Cather C, Deckersbach T, Freudenreich O, Culhane MA, Olm-Shipman CM, Henderson DC, Schoenfeld DA, Goff DC, Rigotti NA.

    J Clin Psychopharmacol. 2005 Jun;25(3):218-25.PMID: 15876899 [PubMed - indexed for MEDLINE]Related articles

    4.

    A comparison of sustained-release bupropion and placebo for smoking cessation.

    Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM.

    N Engl J Med. 1997 Oct 23;337(17):1195-202.PMID: 9337378 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation.

    Muramoto ML, Leischow SJ, Sherrill D, Matthews E, Strayer LJ.

    Arch Pediatr Adolesc Med. 2007 Nov;161(11):1068-74.PMID: 17984409 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.

    Aubin HJ, Lebargy F, Berlin I, Bidaut-Mazel C, Chemali-Hudry J, Lagrue G.

    Addiction. 2004 Sep;99(9):1206-18.PMID: 15317642 [PubMed - indexed for MEDLINE]Related articles

    7.

    A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

    Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

    J Clin Psychopharmacol. 2007 Aug;27(4):380-6.PMID: 17632223 [PubMed - indexed for MEDLINE]Related articles

    8.

    Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.

    Croghan IT, Hurt RD, Dakhil SR, Croghan GA, Sloan JA, Novotny PJ, Rowland KM, Bernath A, Loots ML, Le-Lindqwister NA, Tschetter LK, Garneau SC, Flynn KA, Ebbert LP, Wender DB, Loprinzi CL.

    Mayo Clin Proc. 2007 Feb;82(2):186-95.PMID: 17290726 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial.

    Ahluwalia JS, Harris KJ, Catley D, Okuyemi KS, Mayo MS.

    JAMA. 2002 Jul 24-31;288(4):468-74.PMID: 12132977 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

    Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR; Varenicline Phase 3 Study Group.

    JAMA. 2006 Jul 5;296(1):56-63. Erratum in: JAMA. 2006 Sep 20;296(11):1355. PMID: 16820547 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.

    Fossati R, Apolone G, Negri E, Compagnoni A, La Vecchia C, Mangano S, Clivio L, Garattini S; for the General Practice Tobacco Cessation Investigators Group.

    Arch Intern Med. 2007 Sep 10;167(16):1791-7.PMID: 17846399 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics.

    Hays JT, Hurt RD, Decker PA, Croghan IT, Offord KP, Patten CA.

    Nicotine Tob Res. 2009 Jul;11(7):859-67. Epub 2009 May 29.PMID: 19483180 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effect of bupropion sustained-release on cigarette craving after smoking cessation.

    Durcan MJ, Deener G, White J, Johnston JA, Gonzales D, Niaura R, Rigotti N, Sachs DP.

    Clin Ther. 2002 Apr;24(4):540-51.PMID: 12017399 [PubMed - indexed for MEDLINE]Related articles

    14.

    Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.

    Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA, Fiore MC, Rennard SI, Leischow SJ.

    Clin Ther. 2001 May;23(5):744-52.PMID: 11394732 [PubMed - indexed for MEDLINE]Related articles

    15.

    A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.

    Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, Baker TB.

    Arch Gen Psychiatry. 2009 Nov;66(11):1253-62.PMID: 19884613 [PubMed - indexed for MEDLINE]Related articles

    16.

    A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

    Robles GI, Singh-Franco D, Ghin HL.

    Clin Ther. 2008 May;30(5):800-12. Review.PMID: 18555928 [PubMed - indexed for MEDLINE]Related articles

    17.

    Varenicline: a first-line treatment option for smoking cessation.

    Garrison GD, Dugan SE.

    Clin Ther. 2009 Mar;31(3):463-91. Review.PMID: 19393839 [PubMed - indexed for MEDLINE]Related articles

    18.

    A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.

    Dalsgareth OJ, Hansen NC, Søes-Petersen U, Evald T, Høegholm A, Barber J, Vestbo J.

    Nicotine Tob Res. 2004 Feb;6(1):55-61.PMID: 14982688 [PubMed - indexed for MEDLINE]Related articles

    19.

    A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.

    Covey LS, Glassman AH, Jiang H, Fried J, Masmela J, LoDuca C, Petkova E, Rodriguez K.

    Addiction. 2007 Aug;102(8):1292-302.PMID: 17624979 [PubMed - indexed for MEDLINE]Related articles

    20.

    Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants.

    Chengappa KN, Kambhampati RK, Perkins K, Nigam R, Anderson T, Brar JS, Vemulapalli HK, Atzert R, Key P, Kang JS, Levine J.

    J Clin Psychiatry. 2001 Jul;62(7):503-8.PMID: 11488359 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data